INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 435m ago
House PTR35m ago
SEC 13F34m ago
Robinhood Chain34m ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
CK
Carter Susan KDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$36K
429 sh
Jun 23, 2026Jun 25, 2026
Page 636 of 1737
← PrevNext →
traded Jun 23, 2026
+2d
SEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
26 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

13
WC
Walker Maria CDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
3,932 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

13
MV
Mitchell Adrian VDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$31K
370 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
35 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
70 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,931
13 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
65 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
39 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

12
GN
Gallagher NeilDirector
FHTXFoghorn Therapeutics Inc.
Grant or award
A$114K
28.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

12
DS
Duty StuartDirector
FHTXFoghorn Therapeutics Inc.
Grant or award
A$114K
28.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
15.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

12
TE
Telesz Todd EChief Financial Officer
HNRGHALLADOR ENERGY CO
Option exercise
M$146K
8,219 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

11
WL
Williams William L. IiiDirector
LOBLive Oak Bancshares, Inc.
Open-market sale · 10b5-1 plan
SELL$336K
8,400 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

11
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
1,258 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

11
BS
Bizily ScottChief Legal Officer
FDMT4D Molecular Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$41K
9,810 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

10
KJ
Knopp Kevin J.Director, President and CEO
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$31K
3,422 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2,919
97 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
BR
Boyle RobertSVP, GC and Secretary
PHINPHINIA INC.
Grant or award
A—
53 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
GK
Gefen Lynn KChief People and Legal Officer
TSNDFTerrAscend Corp.
Disposition to issuer
D—
325.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

9
DS
Dori SebastianVP and CPO
PHINPHINIA INC.
Grant or award
A—
25 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
PM
Philip Ron MDirector
AVTXAvalo Therapeutics, Inc.
Grant or award
A—
40.2K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
NL
Newton LatondraDirector
PHINPHINIA INC.
Grant or award
A—
13 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
LL
Luneborg Nanna LiebachDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
14.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
LJ
Linz Terrence JamesPresident, Wholesale Brands
LZBLA-Z-BOY INC
Tax withholding
F$23K
582 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
CK
Carter Susan KDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$3,648
43 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
NL
Newton LatondraDirector
PHINPHINIA INC.
Grant or award
A—
8 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
GZ
Ghanem ZiadPresident and CEO
TSNDFTerrAscend Corp.
Grant or award
A—
350.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

9
RZ
Richmond Raphaell Z.VP, GC & Chief Compliance Off
LZBLA-Z-BOY INC
Tax withholding
F$20K
489 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
5,394 sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence

9
WR
Weerasinghe RohanDirector
PHINPHINIA INC.
Grant or award
A—
19 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
PJ
Palmieri JaneDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$11K
129 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
HD
Hankin Michael DavidDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$12K
146 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
GK
Gefen Lynn KChief People and Legal Officer
TSNDFTerrAscend Corp.
Grant or award
A—
325.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

9
GZ
Ghanem ZiadPresident and CEO
TSNDFTerrAscend Corp.
Disposition to issuer
D—
350.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

9
KJ
Knopp Kevin J.Director, President and CEO
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$149K
16.4K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence